Procedures have not been adequately established to control product that does not conform to specified r equirements.
Inspection Record
Legacy Pharmaceutical Packaging LLC — FDA 483 Findings
Inspectors Edward E LockwoodThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
A process whose results cannot be fully verified by subsequent inspection and test has not been adequately validated according to established procedures.
Rework and reevaluation activities have not been documented in the device history record.
Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established.
Schedules for the adjustment, cleaning, and other maintenance of equipment have not been adequately established.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2020-12-29. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.